Neo Ivy Capital Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-60,282	Closed	-$802K	–	422
2023 Q2	$802K	Buy	+60,282	New	+$802K	0.42%	89
2022 Q4	$11K	Buy	+1,338	New	+$11K	0.01%	299
2021 Q3	–	Sell	-5,143	Closed	-$180K	–	592
2021 Q2	$180K	Buy	+5,143	New	+$180K	0.18%	197